Pegylated Interferon α-2b, Ribavirin and Amantadine for Chronic Hepatitis C

By Younossi Zobair   McCullough Arthur   Barnes David   Post Anthony   Ong Janus   O’shea Robert   Martin Lisa   Bringman Diane   Farmer Denise   Levinthal Gavin   Mullen Kevin   Carey William   Tavill Anthony   Ferguson Roy   Gramlich Terry  

Digestive Diseases and Sciences, Vol. 50, Iss. 5, 2005-05 ,pp. : 970-975

Springer Publishing Company

Access to resources Recommend Favorite

Very-Low-Dose Pegylated Interferon α2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention

By  

Case Reports in Gastroenterology, Vol. 4, Iss. 2, 2010-07 ,pp. : 261-266

Karger

Access to resources Recommend Favorite

Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin

By Sjogren Maria   Sjogren Robert   Lyons Michael   Ryan Michael   Santoro John   Smith Coleman   Reddy K.   Bonkovsky Herbert   Huntley Brooke   Faris-Young Sima  

Digestive Diseases and Sciences, Vol. 52, Iss. 6, 2007-06 ,pp. : 1540-1547

Springer Publishing Company

Access to resources Recommend Favorite

Sustained Viral Response to Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Refractory to Prior Treatment

By Mathew A.   Peiffer L.   Rhoades K.   McGarrity T.  

Digestive Diseases and Sciences, Vol. 51, Iss. 11, 2006-11 ,pp. : 1956-1961

Springer Publishing Company

Access to resources Recommend Favorite

A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C

By Okuse Chiaki   Adachi Kayo   Katakura Yoshiki   Matsunaga Kotaro   Ishii Toshiya   Matsumoto Nobuyuki   Yotsuyanagi Hiroshi   Iino Shiro   Suzuki Michihiro   Itoh Fumio  

Journal of Gastroenterology, Vol. 41, Iss. 12, 2006-12 ,pp. : 1231-1236

Springer Publishing Company

Access to resources Recommend Favorite